Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04740008 · ClinicalTrials.gov registry record · Early Phase 1
Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices
A Early Phase 1 study of Smoking and Cigarette, sponsored by Masonic Cancer Center, University of Minnesota.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 64
- Enrollment target
- 1
- Study location
NCT04740008: Completed Early Phase 1 study of Smoking and Cigarette, sponsored by Masonic Cancer Center, University of Minnesota.
NCT04740008 is a Early Phase 1 study of Smoking and Cigarette that has completed, run by Masonic Cancer Center, University of Minnesota. The registered enrollment target is 64 participants, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04740008, a Early Phase 1 study of Smoking and Cigarette, has completed, sponsored by Masonic Cancer Center, University of Minnesota.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 64 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this research is to evaluate the effects of low nicotine content cigarette (LNC) educational messaging on perceptions of low nicotine cigarettes, tobacco/nicotine product choice preferences (hypothetical), LNC cigarette subjective ratings, and LNC cigarette abuse liability among adult smokers.
Primary Outcome
Proportion of participants who select to use ANDS or no tobacco if LNC cigarettes were the only cigarettes available will be compared in arm 1 versus arm 2
Interventions
- DRUG Low Nicotine Content Cigarettes
- OTHER Control message
- OTHER Test message
Study Locations (1)
Minnesota
- University of Minnesota, Tobacco Research Program, 717 Delaware St., SE - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2021-04-20 |
| Est. Completion | 2022-08-24 |
| Phase | Early Phase 1 |
What the finished NCT04740008 record still lists
NCT04740008 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 455-participant average among 123 other Smoking trials with a reported enrollment target (86% lower).
The record links to 2 conditions, with Smoking appearing as the primary indexed condition, and to 3 interventions - of which Low Nicotine Content Cigarettes is the first listed.
NCT04740008 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04740008 about?
NCT04740008 is a clinical study titled "Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices". The purpose of this research is to evaluate the effects of low nicotine content cigarette (LNC) educational messaging on perceptions of low nicotine cigarettes, tobacco/nicotine product choice preferences (hypothetical), LNC cigarette subjective ratings, and LNC cigarette abuse liability among adult...
What is the current status of trial NCT04740008?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 64 participants. The study started on 2021-04-20. Estimated completion is 2022-08-24.
What conditions does trial NCT04740008 study?
This clinical trial studies the following conditions: Smoking, Cigarette.
What interventions are being tested in trial NCT04740008?
The interventions under investigation include: Low Nicotine Content Cigarettes (DRUG), Control message (OTHER), Test message (OTHER).
Who is sponsoring clinical trial NCT04740008?
This trial is sponsored by Masonic Cancer Center, University of Minnesota, which has 249 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04740008 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Smoking
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04740008's enrollment target sits among peer trials
64 87th of 123 higher than 37 of 123 other Smoking trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Smoking trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer
ACTIVE NOT RECRUITING · Early Phase 1
-
Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)
ACTIVE NOT RECRUITING · Early Phase 1
-
Hollings Cancer Center Varenicline Sampling Study
COMPLETED · Early Phase 1
-
Combination SBIRT for Emergency Department Patients Who Drink and Smoke
COMPLETED · Early Phase 1
-
Integrating Financial Coaching and Smoking Cessation Coaching
RECRUITING · Phase 3
-
Collection of Airway, Blood and/or Urine Specimens From Subjects for Research Studies
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI